Skip to content

SMRI

GradeCNASDAQ Global Market

Bushido Capital US Equity ETF

Active Equity · Bushido · Inception 2023-09-13 · SEC filings

$46.03−0.42 (−0.90%)

As of Sep 23, 2026, 2:20 PM EDT

History starts Sep 14, 2023.
Intraday session: down, 59 prints from 46.45 to 46.03. Range 45.98 to 46.37. Use the arrow keys to read each point.$46.10$46.20$46.30$46.4010 AM12 PM2 PM4 PM
Expense ratio
0.71%
Fund size
$697M
1Y return
+36.1%
Yield · Last 12 months
0.82%
Volume · 30D
0M sh
NAV per share
$46.75
52W range
low $33.63high $50.48

The ETF.net SMRI Grade

C

47/ 100

Rank 36 of 66 in US Active Value

Confidence Medium

Six-pillar profile for SMRI. Scores out of 100: Cost 24, Risk 62, Mission 72, Tradability 58, Holdings 71, Durability 66. Strongest: Mission (72). Weakest: Cost (24). No single pillar leads.
F< 25
D≥ 25
C≥ 40
B≥ 55
A≥ 70

Score 47 of 100 sits in the C band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.

  • Cost

    What you pay to own it — the expense ratio plus trading frictions, ranked within its category.
    FScore 24
    Category rank51/66 · bottom quartile
  • Mission

    How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.
    AScore 72
    Category rank16/27 · mid-pack
  • Risk

    How violently it can move — volatility, drawdown depth, and downside capture versus its category.
    BScore 62
    Category rank19/62 · top 31%
  • Tradability

    How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.
    BScore 58
    Category rank24/66 · top 36%
  • Holdings

    What it actually owns — the quality, breadth, and concentration of the underlying portfolio.
    AScore 71
    Category rank19/66 · top 29%
  • Durability

    Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.
    BScore 66
    Category rank20/66 · top 30%

Graded as of Sep 22, 2026

Our read on SMRI

ETF.net Research

CBushido runs a hands-on value book: fundamental stock picking that mixes quantitative screens with human judgment, in a corner of the market dominated by cheap rules-based factor products. Concentrated by design, and priced like the active fund it is.

Stated mandate

The Fund seeks long-term capital appreciation.

Why people hold it

  1. 01Genuinely active, not an index in disguise: a fundamental value approach combining quantitative and qualitative analysis, run by sub-adviser Sepio Capital.etfarchitect.com
  2. 02Concentrated by design: a few dozen U.S. listed stocks rather than a sprawling factor sweep, so individual picks carry real weight in the portfolio.etfarchitect.comstockanalysis.com
  3. 03The portfolio matches the label closely: at least 80% in U.S. listed common stock, selected on profitability, quality and value. Income is paid quarterly.etfarchitect.com

Worth knowing

  1. 010.72% a year, above the 0.55% median for U.S. value peers and multiples of systematic options like AVLV (0.15%) and DFLV (0.21%). Active judgment is the thing you're paying for.
  2. 02Thinly traded. Limit orders and mid-session fills matter more here than with the household-name value funds.
  3. 03No industry concentration on paper, but the stock selection process can leave the book leaning on a small number of sectors, and those sectors shift over time.etfarchitect.com

SMRI Holdings

As of Sep 20, 2026, 9:25 AM
Asset class
Stocks
Holdings
Top-10 weight
26%
Largest holding
MPC2.9%

Geography

  • United States95.63%
  • Ireland4.37%
The fund’s holdings, weight-ordered — page 1 of 4.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001MPCMarathon Petroleum Corp2.94%48,410$21M391
002VLOValero Energy Corp2.90%49,073$20M395
003WDAYWorkday Inc2.88%103,816$20M389
004VEEVVeeva Systems Inc2.81%75,628$20M314
005PSXPhillips 662.74%70,225$19M368
006CRMSalesforce Inc2.65%78,098$19M457
007THCTenet Healthcare Corp2.49%66,633$17M216
008ACNAccenture PLC2.45%94,631$17M268
009NEMNewmont Corp2.17%123,102$15M428
010ADBEAdobe Inc2.16%60,758$15M475
011GENGEN DIGITAL INC2.15%518,156$15M285
012NTAPNetApp Inc2.15%75,915$15M410
013ADPAutomatic Data Processing Inc2.12%54,640$15M434
014MRKMerck & Co Inc2.11%100,798$15M506
015REGNRegeneron Pharmaceuticals Inc2.09%18,671$15M401

Showing 1–15 of 52 holdings

SMRI Performance

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

SMRI$13,615
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,723
Sep 22, 2025 to Sep 22, 2026. SMRI $13,615. SPY $11,723. Use the arrow keys to read each point.$9,138$11,988$14,837Sep 2025Mar 2026Sep 2026

Sep 22, 2025 – Sep 22, 2026

Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for SMRI. Periods over one year show the average yearly return.
PeriodSMRI
Year to date+28.9%
1 month−4.6%
3 months+13.8%
1 year+36.1%
3 years+25.2%per year
5 yearsFund is under 5 years oldper year
10 yearsFund is under 10 years oldper year

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for SMRI
YearReturn barSMRI
2026 YTD+28.9%
2025+17.4%
2024+19.2%
2023+5.1%

History from Sep 14, 2023

SMRI in the news

ETF.net Research hasn’t filed on SMRI yet — coverage lands here as it’s written.

SMRI Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Sep 22, 2026.
0.82%Last 12 months
Payout per share
$0.38Last 12 months
Last payment
$0.03 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2023–2026

One bar per payment. 8 payments from 2023 to 2026 YTD. Dec 20, 2023 $0.12; Dec 30, 2024 $0.31; Mar 28, 2025 $0.14; Jun 27, 2025 $0.06; Sep 29, 2025 $0.15; Dec 23, 2025 $0.13; Mar 30, 2026 $0.07; Jun 29, 2026 $0.03. Use the arrow keys to read each point.2023202420252026YTD
Ex-datePay dateAmount per share
Jun 29, 2026Jun 30, 2026$0.03
Mar 30, 2026Mar 31, 2026$0.07
Dec 23, 2025Dec 24, 2025$0.13
Sep 29, 2025Sep 30, 2025$0.15
Jun 27, 2025Jun 30, 2025$0.06
Mar 28, 2025Mar 31, 2025$0.14
Dec 30, 2024Dec 31, 2024$0.31
Dec 20, 2023Dec 22, 2023$0.12

SMRI Risk

How much the fund’s monthly returns vary, scaled to a year.
15.3%
Annualised · 35 months to Aug 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
1.41
vs 3-month T-bills · 35 months to Aug 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−18.4%
36 months · trough Apr 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.86
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

SMRI Cost

Expense ratio0.71%
  • The middle half of US Active Value funds
  • Median 0.55%

49 of the 66 US Active Value funds charge less.

SMRI costs $71.00 a year on $10,000. The median US Active Value fund costs $55.00.